BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31183644)

  • 1. Relaxation Properties of Contrast Media for MRI Based on Iron Oxide Nanoparticles in Different Magnetic Fields.
    Chekhonin VP; Abakumov MA; Mazhuga AG; Bagdinova AN; Demikhov EI; Demikhov TE; Mishkinis BY; Konstantinov MV; Tarasov VP; Shumm BA; Gippius AA; Gervits NV; Shumm AB
    Bull Exp Biol Med; 2019 May; 167(1):97-99. PubMed ID: 31183644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of the 1H NMR relaxation enhancement produced by iron oxide and core-shell iron-iron oxide nanoparticles.
    Miguel OB; Gossuin Y; Morales MP; Gillis P; Muller RN; Veintemillas-Verdaguer S
    Magn Reson Imaging; 2007 Dec; 25(10):1437-41. PubMed ID: 17566686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-triphosphate nanoparticles for encapsulation of super-paramagnetic iron oxide as an MRI contrast agent.
    Sanjai C; Kothan S; Gonil P; Saesoo S; Sajomsang W
    Carbohydr Polym; 2014 Apr; 104():231-7. PubMed ID: 24607182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of surfactants on the magnetic properties of iron oxide colloids.
    Soares PI; Alves AM; Pereira LC; Coutinho JT; Ferreira IM; Novo CM; Borges JP
    J Colloid Interface Sci; 2014 Apr; 419():46-51. PubMed ID: 24491328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron Oxide Nanoparticle Based Contrast Agents for Magnetic Resonance Imaging.
    Shen Z; Wu A; Chen X
    Mol Pharm; 2017 May; 14(5):1352-1364. PubMed ID: 27776215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast Agents Based on Iron Oxide Nanoparticles for Clinical Magnetic Resonance Imaging.
    Abakumov MA; Ternovoi SK; Mazhuga AG; Chekhonin VP; Demikhov EI; Pistrak AG; Konstantinov MV; Dmitriev DM; Myshkinis BY
    Bull Exp Biol Med; 2019 Jun; 167(2):272-274. PubMed ID: 31243671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relaxation behavior study of ultrasmall superparamagnetic iron oxide nanoparticles at ultralow and ultrahigh magnetic fields.
    Wang W; Dong H; Pacheco V; Willbold D; Zhang Y; Offenhaeusser A; Hartmann R; Weirich TE; Ma P; Krause HJ; Gu Z
    J Phys Chem B; 2011 Dec; 115(49):14789-93. PubMed ID: 21972868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging of endothelial cells with vectorized iron oxide nanoparticles.
    Abakumov MA; Goldt AE; Sokolsky-Papkov M; Zorkina YA; Baklaushev VP; Goodilin EA; Kabanov AV; Chekhonin VP
    Bull Exp Biol Med; 2011 Oct; 151(6):726-30. PubMed ID: 22485218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleaved iron oxide nanoparticles as T2 contrast agents for magnetic resonance imaging.
    Jeon SL; Chae MK; Jang EJ; Lee C
    Chemistry; 2013 Mar; 19(13):4217-22. PubMed ID: 23345158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hot-injection synthesis of iron/iron oxide core/shell nanoparticles for T2 contrast enhancement in magnetic resonance imaging.
    Herman DA; Ferguson P; Cheong S; Hermans IF; Ruck BJ; Allan KM; Prabakar S; Spencer JL; Lendrum CD; Tilley RD
    Chem Commun (Camb); 2011 Aug; 47(32):9221-3. PubMed ID: 21761066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diblock-copolymer-mediated self-assembly of protein-stabilized iron oxide nanoparticle clusters for magnetic resonance imaging.
    Tähkä S; Laiho A; Kostiainen MA
    Chemistry; 2014 Mar; 20(10):2718-22. PubMed ID: 24523066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictable Heating and Positive MRI Contrast from a Mesoporous Silica-Coated Iron Oxide Nanoparticle.
    Hurley KR; Ring HL; Etheridge M; Zhang J; Gao Z; Shao Q; Klein ND; Szlag VM; Chung C; Reineke TM; Garwood M; Bischof JC; Haynes CL
    Mol Pharm; 2016 Jul; 13(7):2172-83. PubMed ID: 26991550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superparamagnetic iron oxide based nanoprobes for imaging and theranostics.
    Lam T; Pouliot P; Avti PK; Lesage F; Kakkar AK
    Adv Colloid Interface Sci; 2013 Nov; 199-200():95-113. PubMed ID: 23891347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesoscale assemblies of iron oxide nanocubes as heat mediators and image contrast agents.
    Materia ME; Guardia P; Sathya A; Leal MP; Marotta R; Di Corato R; Pellegrino T
    Langmuir; 2015 Jan; 31(2):808-16. PubMed ID: 25569814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key Parameters on the Microwave Assisted Synthesis of Magnetic Nanoparticles for MRI Contrast Agents.
    Brollo MEF; Veintemillas-Verdaguer S; Salván CM; Morales MDP
    Contrast Media Mol Imaging; 2017; 2017():8902424. PubMed ID: 29348738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembly system of direct modified superparamagnetic iron oxide nanoparticles for target-specific MRI contrast agents.
    Tanaka K; Kitamura N; Morita M; Inubushi T; Chujo Y
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5463-5. PubMed ID: 18829309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomes Loaded with Hydrophobic Iron Oxide Nanoparticles: Suitable T₂ Contrast Agents for MRI.
    Martínez-González R; Estelrich J; Busquets MA
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27472319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance relaxation properties of superparamagnetic particles.
    Gossuin Y; Gillis P; Hocq A; Vuong QL; Roch A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):299-310. PubMed ID: 20049798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron-oxide-based twin nanoplates with strong T
    Wei R; Zhou T; Sun C; Lin H; Yang L; Ren BW; Chen Z; Gao J
    Nanoscale; 2018 Oct; 10(38):18398-18406. PubMed ID: 30256373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface functionalization of magnetic iron oxide nanoparticles for MRI applications - effect of anchoring group and ligand exchange protocol.
    Smolensky ED; Park HY; Berquó TS; Pierre VC
    Contrast Media Mol Imaging; 2011; 6(4):189-99. PubMed ID: 21861279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.